ELOVL6 and acute myeloid leukemia: By contrast, 10 out of 14 recipients died due to AML following E6KO MA9Flag-E6 cell transplantation (Fig. 2C), suggesting the re-acquisition of leukemogenic potential following Elovl6 re-expression.